Riverwater Partners’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-103,414
| Closed | -$265K | – | 222 |
|
|
2024
Q3 | $265K | Sell |
103,414
-2,563
| -2% | -$6.56K | 0.13% | 178 |
|
|
2024
Q2 | $302K | Buy |
105,977
+12,780
| +14% | +$36.4K | 0.22% | 139 |
|
|
2024
Q1 | $395K | Buy |
93,197
+11,492
| +14% | +$48.7K | 0.29% | 107 |
|
|
2023
Q4 | $437K | Buy |
81,705
+223
| +0.3% | +$1.19K | 0.34% | 84 |
|
|
2023
Q3 | $350K | Buy |
81,482
+37,171
| +84% | +$160K | 0.32% | 102 |
|
|
2023
Q2 | $243K | Sell |
44,311
-13,008
| -23% | -$71.4K | 0.22% | 157 |
|
|
2023
Q1 | $241K | Hold |
57,319
| – | – | 0.22% | 152 |
|
|
2022
Q4 | $159K | Hold |
57,319
| – | – | 0.14% | 192 |
|
|
2022
Q3 | $147K | Sell |
57,319
-35,886
| -39% | -$92K | 0.15% | 183 |
|
|
2022
Q2 | $336K | Buy |
93,205
+62
| +0.1% | +$224 | 0.34% | 105 |
|
|
2022
Q1 | $578K | Hold |
93,143
| – | – | 0.95% | 44 |
|
|
2021
Q4 | $657K | Buy |
+93,143
| New | +$657K | 0.58% | 51 |
|